Why the study?
The supplement was published to mark the 10th anniversary of the EPMA and highlight advances in predictive, preventive, and personalised medicine.
Key points are not available for this paper at this time.
Offers overview of PPPM advances for clinicians; leaves open validation in prospective cardiovascular trials.
In 2019, the EPMA celebrated its 10th anniversary at the 5th World Congress in Pilsen, Czech Republic. The history of the International Professional Network dedicated to Predictive, Preventive and Personalised Medicine (PPPM / 3PM) is rich in achievements. Facing the coronavirus COVID-19 pandemic it is getting evident globally that the predictive approach, targeted prevention and personalisation of medical services is the optimal paradigm in healthcare demonstrating the high potential to save lives and to benefit the society as a whole. The EPMA World Congress Supplement 2020 highlights advances in 3P medicine.
No takes yet. Share an insight, caveat, or question.
Golubnitschaja et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: